Gliatech hires outsider for corrective actions:
This article was originally published in Clinica
Executive Summary
Gliatech has hired an external auditor for corrective actions and future filings to the FDA under the regulator's Application Integration Policy (AIP). Gliatech recalled its Adcon-L anti-adhesion gel in January following possible contamination and was placed on a special FDA AIP watch list following earlier post approval trials which were conducted unacceptably (see Clinica No 943 p 11).